Infertility: Which Blood Tests Are Commonly Used?

Medical & affiliate disclosure: CTX Stat provides educational laboratory information and is not a substitute for professional medical advice, diagnosis, or treatment. CTX Stat may receive compensation from some outbound provider links when an affiliate program is active; provider comparisons and rankings are based on consumer fit, effective cost, access, policies, and reputation—not commission.

Quick take

Blood tests for infertility help identify hormone patterns, ovarian reserve, ovulation, thyroid or prolactin problems, androgen excess, and selected genetic or immune factors that may affect the chance of pregnancy. They are useful, but they are not the whole infertility workup. A complete evaluation often also includes a careful history, semen analysis, pelvic ultrasound, and testing of the uterus and fallopian tubes.

• Common female-focused blood tests include anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH), estradiol, progesterone, thyroid-stimulating hormone (TSH), prolactin, luteinizing hormone (LH), and androgen-related tests when indicated.
• Common male-focused blood tests include FSH and testosterone when semen results, symptoms, or exam findings suggest a hormone or sperm-production problem; LH, prolactin, estradiol, and genetic testing may be added in selected cases.
• Timing matters. FSH and estradiol are often measured early in the menstrual cycle; progesterone is usually measured about one week before the expected period; AMH can generally be drawn on any cycle day.
• Interpretation is individualized. Fertility bloodwork is interpreted with age, cycle pattern, ultrasound findings, semen analysis, medications, medical history, and the couple’s or individual’s reproductive goals.

On this page

• Why blood tests are used in infertility
• Common blood tests for female-factor evaluation
• Blood tests used in male infertility evaluation
• Timing and preparation
• Cost and insurance considerations
• FAQs

Why blood tests are used in infertility

Infertility is not a single diagnosis. It can involve ovulation, ovarian reserve, fallopian tube function, uterine anatomy, sperm production or transport, endocrine disorders, genetics, age-related egg quality, or more than one factor at the same time. Blood tests are one part of sorting out those possibilities.

The American Society for Reproductive Medicine (ASRM) emphasizes that fertility evaluation should be systematic and should use tests that change counseling or management. In its guidance on evaluating infertile women, ASRM describes ovarian reserve testing as an adjunct to evaluation, not a stand-alone screening tool for everyone. It also notes that thyroid dysfunction, hyperprolactinemia, and androgen-excess conditions may need evaluation when symptoms or cycle patterns suggest them. ASRM: Fertility evaluation of infertile women

Blood tests can answer questions such as:

• Is ovulation likely occurring?
• Is ovarian reserve lower or higher than expected for age?
• Could thyroid disease or high prolactin be disrupting ovulation?
• Is there biochemical evidence of androgen excess, as seen in some people with polycystic ovary syndrome (PCOS) or adrenal conditions?
• In men, do hormone patterns suggest primary testicular failure, pituitary signaling problems, or another endocrine contributor?
• Are there selected genetic, infectious disease, or preconception issues that should be addressed before treatment?

Just as important: blood tests have limits. They do not directly show whether the fallopian tubes are open, whether the uterus has a septum, fibroids, adhesions, or polyps, or whether sperm count and motility are normal. They also cannot promise whether pregnancy will occur naturally. That is why fertility specialists interpret bloodwork alongside imaging, semen analysis, cycle history, and treatment goals.

Common blood tests for female-factor infertility evaluation

The exact panel varies. Some clinicians order a broad first-line panel; others order targeted testing based on menstrual history, age, ultrasound, and symptoms. The table below explains commonly used tests and the practical question each one helps answer.

Blood test	What it helps evaluate	Typical timing	Important limitations
AMH	Ovarian reserve; expected response to ovarian stimulation	Often any cycle day	Does not by itself predict natural conception in a specific cycle
FSH	Pituitary signal to the ovary; part of ovarian reserve assessment	Usually cycle day 2, 3, or 4	Must be interpreted with estradiol and age; can vary between cycles
Estradiol	Early follicular estrogen level; helps interpret FSH	Usually with day-2 to day-4 FSH	A high early estradiol can suppress FSH and mask ovarian reserve concerns
Progesterone	Evidence that ovulation likely occurred	About 7 days before expected period	A mistimed draw can look falsely low
TSH, sometimes free T4	Thyroid function that may affect cycles and pregnancy planning	Any day	Abnormal TSH may need confirmation and context-specific pregnancy targets
Prolactin	High prolactin that can disrupt ovulation	Often morning; repeat if mildly elevated	Stress, breast stimulation, medications, and macroprolactin can affect results
LH	Pituitary-ovarian signaling; sometimes used in PCOS or ovulation assessment	Varies by purpose	LH fluctuates; the LH-to-FSH ratio is not diagnostic by itself
Testosterone, DHEA-S, 17-hydroxyprogesterone	Androgen excess, PCOS-related evaluation, adrenal sources, nonclassic congenital adrenal hyperplasia	Often morning; cycle timing may be specified	Should be ordered when symptoms or cycle pattern support the question

AMH: ovarian reserve, not a pregnancy guarantee

Anti-Müllerian hormone is produced by cells around developing ovarian follicles. In fertility care, AMH is widely used as a marker of ovarian reserve and as a way to estimate how the ovaries may respond to stimulation medications. Lower AMH can suggest a lower remaining pool of recruitable follicles; higher AMH is often seen in PCOS and may suggest a higher response to stimulation.

AMH is useful, but it is commonly misunderstood. A low AMH does not automatically mean a person cannot conceive without treatment, and a high AMH does not guarantee easy conception. ACOG notes that AMH is useful for predicting ovarian response in fertility treatment settings, but routine AMH testing in people not seeking fertility care is not supported as a reliable way to predict time to pregnancy. ACOG: Use of AMH in women not seeking fertility care

In an infertility workup, AMH is most helpful when it is combined with age, antral follicle count on ultrasound, cycle history, prior ovarian surgery, endometriosis history, chemotherapy or radiation exposure, and treatment goals such as intrauterine insemination (IUI), in vitro fertilization (IVF), or fertility preservation.

FSH and estradiol: early-cycle ovarian signaling

FSH is a pituitary hormone that stimulates ovarian follicles. In many fertility evaluations, FSH is measured early in the menstrual cycle, commonly on cycle day 2, 3, or 4, together with estradiol. A higher early-cycle FSH can suggest that the pituitary is working harder to stimulate the ovary, which may be seen with diminished ovarian reserve. Estradiol helps interpret the result because an elevated early estradiol level can suppress FSH and make the FSH appear more reassuring than it really is.

ASRM describes basal FSH with estradiol and AMH as biochemical tests used to assess ovarian reserve, while also cautioning that ovarian reserve tests should not replace counseling based on age and diagnosis. ASRM: Fertility evaluation guidance

Progesterone: checking whether ovulation likely occurred

Progesterone rises after ovulation because the corpus luteum produces it during the luteal phase. A blood progesterone test can help confirm that ovulation likely occurred, but timing is critical. The common phrase “day-21 progesterone” only fits a roughly 28-day cycle. A more accurate approach is to draw progesterone about 7 days before the expected period.

For example, someone with a 35-day cycle may need progesterone around cycle day 28, not day 21. A test drawn too early or too late may be low even if ovulation occurred. ACOG describes progesterone testing as a blood test taken about one week before the expected menstrual period to help assess ovulation. ACOG: Evaluating infertility

TSH and thyroid testing

Thyroid dysfunction can contribute to irregular cycles, ovulatory problems, pregnancy complications, and symptoms that overlap with reproductive hormone disorders. TSH is the usual first-line thyroid screening test. If TSH is abnormal, clinicians may add free T4 and sometimes thyroid antibody testing, especially when pregnancy planning is involved.

Thyroid interpretation in fertility care may differ from general wellness screening because clinicians consider pregnancy goals, miscarriage history, symptoms, antibody status, and medication use. ASRM’s amenorrhea guidance lists TSH among first-line tests for reproductive-age women with menstrual abnormalities, and its infertility guidance notes that abnormal TSH may warrant free T4 and thyroid antibody assessment. ASRM: Evaluation of amenorrhea

Prolactin: when high levels interfere with ovulation

Prolactin is a pituitary hormone best known for its role in lactation. When prolactin is elevated outside pregnancy or breastfeeding, it can suppress reproductive hormone signaling and lead to irregular periods, absent periods, or anovulation. Prolactin testing is especially relevant when cycles are absent or infrequent, there is milky nipple discharge, headaches or vision symptoms, or medications known to raise prolactin are being used.

A mildly high prolactin result often needs repeat testing because prolactin can rise transiently with stress, recent exercise, breast or nipple stimulation, sexual activity, sleep, and some medications. Clinicians may also evaluate thyroid function because hypothyroidism can contribute to elevated prolactin. ASRM notes that prolactin is not necessarily part of every routine infertility evaluation, but is indicated when menstrual irregularity, amenorrhea, oligomenorrhea, or galactorrhea suggests it. ASRM: Prolactin in infertility evaluation

LH, testosterone, DHEA-S, and 17-hydroxyprogesterone

Androgen-related blood tests are often used when the history suggests PCOS or another cause of androgen excess. Clues include irregular or infrequent periods, acne, increased facial or body hair, scalp hair thinning, or ultrasound findings consistent with polycystic ovarian morphology. Tests may include total testosterone, free testosterone or calculated free androgen measures, DHEA-S, and sometimes 17-hydroxyprogesterone to screen for nonclassic congenital adrenal hyperplasia.

LH may be ordered as part of the broader picture, but an elevated LH-to-FSH ratio is not required to diagnose PCOS and should not be interpreted in isolation. PCOS is a clinical diagnosis based on defined criteria after excluding conditions that can mimic it. Blood tests help clarify the pattern and rule out related endocrine disorders.

Pregnancy test, CBC, immunity, infectious disease, and preconception labs

Not every blood test ordered during infertility care is a diagnostic infertility test. Some are preconception or treatment-safety tests. A quantitative or qualitative hCG blood test may be used to rule out pregnancy before certain medications, procedures, or imaging. A complete blood count (CBC), blood type and Rh factor, rubella and varicella immunity, hepatitis B and C, HIV, syphilis, and other infectious disease tests may be ordered before fertility treatment, donor gametes, IVF, or pregnancy attempts. These tests help reduce preventable risks and meet clinic, laboratory, or regulatory requirements.

Blood tests used in male infertility evaluation

Male-factor infertility is common enough that semen analysis is usually an early part of the evaluation, not a last resort. Blood tests are not always the first male test; they are usually added when semen analysis, symptoms, or physical examination suggests a hormonal, testicular, pituitary, or genetic issue.

The AUA/ASRM male infertility guideline recommends hormonal evaluation including FSH and testosterone for infertile men with impaired libido, erectile dysfunction, oligozoospermia or azoospermia, atrophic testes, or other signs of hormonal abnormality. It also recommends selected genetic testing, such as karyotype and Y-chromosome microdeletion analysis, for certain men with azoospermia or severe oligospermia when findings suggest impaired sperm production. AUA/ASRM: Male infertility guideline, Part I

Male blood test	Why it may be ordered	How it is interpreted
FSH	Evaluates pituitary signal to the testes and sperm production pattern	High FSH with very low sperm count may suggest impaired sperm production
Total testosterone	Assesses androgen status, libido concerns, erectile dysfunction, or endocrine symptoms	Often drawn in the morning; low results may require repeat confirmation
LH	Helps distinguish primary testicular from pituitary or hypothalamic patterns	Interpreted with testosterone and FSH
Prolactin	Considered when testosterone is low, libido is low, or pituitary causes are suspected	High prolactin can suppress reproductive hormone signaling
Estradiol	Sometimes ordered with obesity, gynecomastia, testosterone imbalance, or medication decisions	Interpreted by a reproductive urologist or endocrinology-trained clinician
Karyotype, Y-chromosome microdeletion, CFTR testing	Used in selected severe sperm abnormalities or suspected congenital absence of the vas deferens	Can affect treatment options, sperm retrieval planning, and genetic counseling

One practical caution: testosterone treatment can suppress sperm production. Men trying to conceive should tell their clinician about testosterone injections, gels, pellets, anabolic steroids, supplements marketed for bodybuilding, and medications affecting hormones. Treatment decisions for male infertility should be coordinated with a clinician who understands fertility goals.

Blood tests sometimes used for recurrent pregnancy loss or treatment planning

Recurrent pregnancy loss is related to infertility care but has a different evaluation. Depending on the history, clinicians may order thyroid tests, diabetes screening, antiphospholipid antibody testing, parental karyotypes, or other targeted labs. These are not automatically appropriate for everyone who has not conceived, but they may be important when there have been repeated miscarriages, late losses, clotting history, autoimmune disease, or suggestive family history.

Before IVF or other assisted reproductive technology, clinics may also order ovarian reserve tests, infectious disease screening, genetic carrier screening, and baseline metabolic or safety labs. The CDC defines assisted reproductive technology as fertility treatments in which eggs or embryos are handled, and provides national ART information and clinic data for consumers considering IVF. CDC: About ART

Timing and preparation for infertility bloodwork

Preparation depends on the test and the reason it is ordered. Always follow the ordering clinician’s instructions, because fertility clinics often use specific timing protocols.

• Cycle-day testing: FSH and estradiol are commonly drawn on cycle day 2, 3, or 4. Cycle day 1 is the first day of full menstrual flow, not spotting.
• Progesterone timing: Aim for about 7 days before the expected period. If cycles are irregular, ovulation predictor kits, basal body temperature, ultrasound monitoring, or repeat testing may be used to improve timing.
• AMH timing: AMH is often less cycle-dependent than FSH or estradiol, so many clinicians allow it to be drawn on any day. Some hormonal contraceptives and ovarian suppression states may affect interpretation.
• Morning tests: Testosterone is often drawn in the morning, especially in men. Prolactin may also be repeated in the morning under calm conditions if mildly elevated.
• Fasting: Most reproductive hormone tests do not require fasting. Fasting may be requested for glucose, insulin, lipid, or metabolic testing, especially in PCOS evaluation.
• Medication review: Bring a complete list of prescriptions, over-the-counter drugs, hormones, supplements, biotin, and fertility medications. Biotin can interfere with some immunoassay-based lab tests, and hormone medications can change reproductive hormone results.

How to interpret results without over-reading them

Infertility bloodwork is pattern-based. One value rarely tells the whole story. A clinician may look at whether the menstrual history suggests ovulation, whether progesterone supports that ovulation occurred, whether AMH and antral follicle count agree, whether FSH and estradiol were drawn at the right time, and whether thyroid or prolactin abnormalities are significant enough to treat.

Examples of common interpretation patterns include:

• Irregular periods plus high androgens: May support PCOS or another androgen-excess condition, but mimicking disorders should be excluded.
• High FSH with low estradiol in absent periods: May suggest ovarian insufficiency, depending on age and repeat testing.
• Low or normal FSH with low estradiol and absent periods: May suggest hypothalamic or pituitary signaling issues, often requiring a different evaluation.
• Low AMH with normal cycles: May affect urgency or treatment planning, but does not alone prove sterility.
• Very low sperm count plus abnormal FSH or testosterone: May prompt reproductive urology evaluation and genetic testing.

The most productive next question is not simply “Is my result normal?” but “What does this result change about my next step?” That next step might be timed intercourse guidance, ovulation induction, thyroid or prolactin treatment, semen analysis, ultrasound, tubal testing, reproductive endocrinology referral, reproductive urology referral, or IVF counseling.

Cost and insurance considerations

The cost of blood tests for infertility varies widely. Pricing depends on whether testing is ordered through an OB-GYN, reproductive endocrinologist, reproductive urologist, direct-to-consumer lab platform, hospital outpatient lab, or independent laboratory. Insurance coverage also varies by state, employer plan, diagnosis code, network status, deductible, and whether the test is considered diagnostic infertility care, preconception care, genetic testing, or treatment monitoring.

When comparing options, look at the effective total cost, not only the advertised lab price. Ask whether the quoted amount includes the provider visit, lab order, blood draw fee, lab processing, platform or service fee, specimen handling, required follow-up, and any repeat testing. If a fertility clinic requires labs to be performed at a specific laboratory before treatment, an outside cash-pay result may not be accepted.

For insurance, ask the ordering office and insurer these questions before testing when possible:

• Is the laboratory in network?
• Will infertility diagnosis codes affect coverage?
• Are ovarian reserve tests, AMH, genetic tests, or infectious disease screening covered?
• Will I owe separate phlebotomy, facility, or handling fees?
• Does my plan require prior authorization for genetic testing?
• Will repeat monitoring labs during treatment be billed differently from the initial evaluation?

Direct access testing may be convenient for some consumers, but infertility interpretation is not just about obtaining numbers. Results should be reviewed with a qualified clinician, especially if they are abnormal, discordant, or being used to make time-sensitive treatment decisions.

What to ask your clinician after infertility blood tests

• Were all cycle-timed tests drawn on the correct day?
• Do my results suggest ovulation, anovulation, diminished ovarian reserve, PCOS, thyroid disease, high prolactin, or another pattern?
• Do any results need to be repeated before making decisions?
• How do these results fit with my age, ultrasound, semen analysis, and how long we have been trying?
• Do we still need semen analysis, pelvic ultrasound, hysterosalpingogram, saline sonogram, or other non-blood testing?
• Should my partner have blood tests or see a reproductive urologist?
• Would treatment change if we tried oral ovulation medication, IUI, IVF, surgery, thyroid treatment, prolactin treatment, or lifestyle changes?

FAQs about blood tests for infertility

What blood tests are usually ordered first for infertility?

Common first tests may include AMH, early-cycle FSH and estradiol, progesterone timed to the luteal phase, TSH, and selected tests such as prolactin, LH, testosterone, DHEA-S, or 17-hydroxyprogesterone when cycles are irregular or androgen symptoms are present. The exact starting panel depends on age, cycle regularity, symptoms, pregnancy history, and clinician preference.

Can blood tests tell if my fallopian tubes are blocked?

No. Blood tests cannot show whether the fallopian tubes are open. Tubal evaluation usually requires imaging, such as a hysterosalpingogram, sonohysterography with contrast, or laparoscopy in selected cases. This is one reason normal bloodwork does not always mean the infertility evaluation is complete.

Can blood tests replace semen analysis?

No. Male hormone blood tests can identify endocrine patterns, but semen analysis directly evaluates sperm count, movement, and shape. A semen analysis is usually a central test when a couple is having difficulty conceiving.

Is AMH the most important fertility blood test?

AMH is important for ovarian reserve and treatment planning, but it is not the only important test and it should not be used alone. Age remains a major predictor of egg quality and fertility treatment success. Ovulation, sperm factors, tubal status, uterine anatomy, and overall health also matter.

Why would my clinician repeat prolactin or testosterone?

Some hormones fluctuate or are affected by timing, stress, sleep, meals, medications, and lab variability. Testosterone is often confirmed with a morning repeat test when low. Mild prolactin elevation may be repeated under controlled conditions before further imaging or treatment is considered.

Do normal infertility blood tests mean everything is fine?

Not necessarily. Normal bloodwork is reassuring for the questions it addresses, but it does not rule out tubal disease, endometriosis, uterine cavity problems, sperm abnormalities, timing issues, or unexplained infertility. Follow-up testing may still be appropriate.

Should I order infertility blood tests on my own?

Self-ordered tests may provide access and price transparency, but fertility testing is highly context-dependent. If you use direct access testing, consider sharing results with an OB-GYN, reproductive endocrinologist, reproductive urologist, or primary care clinician who can interpret them with your history and recommend next steps.

 

Sources

• American Society for Reproductive Medicine: Fertility evaluation of infertile women, committee opinion
• American College of Obstetricians and Gynecologists: Evaluating infertility
• Centers for Disease Control and Prevention: Infertility frequently asked questions
• AUA/ASRM: Diagnosis and treatment of infertility in men, guideline Part I
• American Society for Reproductive Medicine: Current evaluation of amenorrhea
• Centers for Disease Control and Prevention: About assisted reproductive technology